Uboy it doesnt seem right
UBoy that conversation i had with JG was that we do a discounted raise to a US fund say for $8 to $10Mil as a teaser to get in on the cheap so o speak
and in return they would back us into a US IPO for around $100mil colectively if our result are FDA worthy of taking this to market
So now we have the $8mil i am hoping that if the results are up to scratch they will not partner
they should have now have enough funds to take us to the FDA decision
At this point i would look to our $10mil backer to stand to the ipo on the nasdaq backing us into the US with an accelerated approval
This would see us with $100mil IPO funding
a Voucher worth $100mil +
And after talking to banks on the back of the listing would look to a bank loan to the tune of say another $150mil on potential future sales
At this point i would then invite expressions of nterest that have already done due diligence back to the table
i see no reason why we could not be the next REATA whom got FDA approval for Skyclarys which is a lesser market than the DMD market
They armed theirselves with intent ( FUNDS ) and were taken out for $6.5Bil
When i say this could have been so different in my last post this is what i am talking about
this is what i honestly believe results going our way, we could and should be looking towards
But hey these are my opinons and research shared in our group and i seriously believe this could be us if played out strategically
And i would invite anyone in here to dispute that comparison on a factual basis should we be succesful
"if this were to pan out this $8mil discounted issue would faid into insignificance in comparison to the direction it could lead us into
Instead of some chaep ass dowgraded expression of a partneship we have been fed
I still maintain the ROCH - SAREPTA deal was and
still is the benchmark for a minimum partnering deal not a take over
But they are just my opinions and opinions i will not constantly ram down the throats of people in this forum
Add to My Watchlist
What is My Watchlist?
